Stories 3 results of 32

EU OK’s Synedgen

Company wins patent for inflammation drug

Claremont-based biotech company Synedgen Inc. has been granted a European Union patent for its drug to treat GI inflammation related to cancer treatment.

Amgen to Partner with AstraZeneca on Inflammatory Drugs

Amgen Inc. and AstraZeneca Plc said that they will jointly develop and sell five experimental, antibody-based drugs from Amgen's inflammation portfolio.

Children’s Hospital Los Angeles Awarded $1.5 Million Research Grant

Children’s Hospital Los Angeles has been awarded a $1.5 million federal research grant to study what triggers inflammatory bowel disease in more than 1.5 million adults and children, officials said Monday.

Tease photo

More Stories

Create search alert for "서울시강남구로미로미◆라인 GTTG5◆서울시강남구로미로미출장㬢서울시강남구마사지ୋ서울시강남구마사지샵螃서울시강남구마사지업소🙎inflammability"